Transcultural Diabetes Care in The United States – A Position Statement by the American Association of Clinical Endocrinologists
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The American Association of Clinical Endocrinologists (AACE) has created a transculturalized diabetes chronic disease care model that is adapted for patients across a spectrum of ethnicities and cultures. AACE has conducted several transcultural activities on global issues in clinical endocrinology, and completed a 3-city series of conferences in December 2017 that focused on diabetes care for ethnic minorities in the U.S. Proceedings from the "Diabetes Care Across America" series of transcultural summits are presented here. Information from community leaders, practicing health care professionals, and other stakeholders in diabetes care is analyzed according to biological and environmental factors. Four specific U.S. ethnicities are detailed: African Americans, Latino/Hispanics, Asian Americans, and Native Americans. A core set of recommendations to culturally adapt diabetes care is presented that emphasizes culturally appropriate terminology, transculturalization of white papers, culturally adapting clinic infrastructure, flexible office hours, behavioral medicine especially motivational interviewing and building trust, culturally competent nutritional messaging and health literacy, community partnerships for care delivery, technology innovation, clinical trial recruitment and retention of ethnic minorities, and more funding for scientific studies on epigenetic mechanisms of cultural impact on disease expression. It is hoped that through education, research, and clinical practice enhancements, diabetes care can be optimized in terms of precision and clinical outcomes for the individual and U.S. population as a whole.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 22×
“In a pharmacogenomics study involving Taiwanese patients with T2D, there were 45 gene variants associated with therapeutic responses to dipeptidyl peptidase-4 inhibitors, with an affirmation that b-cell dysfunction plays more of an etiologic role than insulin resistance in Asians (264).”
BackgroundInfluentialEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · cited 1×
“For instance, among the major cardiovascular outcome trials, 67 to 83% of participants were Caucasians, compared with only 1 to 7% American Islanders/Alaska Natives/others, 3 to 8% African Americans, 7 to 21% Latino/Hispanics, and 9 to 22% Asians (Table 6) (124-133).”
BackgroundSemaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470 · cited 2×
“Savor-Timi-53 (126,127) Saxagliptin 75 NR 3.”
BackgroundSelf-citationOrganizing Care for Patients with Chronic Illness
Wagner, E. H., Austin, B. T., & Korff, M. V. (1996) · The Milbank Quarterly · doi:10.2307/3350391 · Cited by 2,877 · cited 1×
“Clinical Practice The impact of cultural factors on the performance of the diabetes Chronic Care Model (307,308), as assessed by the Patient Assessment of Chronic Illness Care, remains unclear (309).”
MethodEffect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Green, J. B., Bethel, M. A., Armstrong, P. W., Buse, J. B., Engel, S. S., Garg, J., Josse, R., Kaufman, K. D., Koglin, J., Korn, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501352 · Cited by 2,577 · cited 1×
“For instance, among the major cardiovascular outcome trials, 67 to 83% of participants were Caucasians, compared with only 1 to 7% American Islanders/Alaska Natives/others, 3 to 8% African Americans, 7 to 21% Latino/Hispanics, and 9 to 22% Asians (Table 6) (124-133).”
BackgroundAlogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502 · cited 1×
“For instance, among the major cardiovascular outcome trials, 67 to 83% of participants were Caucasians, compared with only 1 to 7% American Islanders/Alaska Natives/others, 3 to 8% African Americans, 7 to 21% Latino/Hispanics, and 9 to 22% Asians (Table 6) (124-133).”
BackgroundNew genetic loci link adipose and insulin biology to body fat distribution
The ADIPOGen Consortium, Shungin, D., The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The GEFOS Consortium, The GENIE Consortium, The, G. L. G. C., The, I. C. B. P., The International Endogene Consortium, Study, T. L. C., et al. (2015) · Nature · doi:10.1038/nature14132 · Cited by 1,580
The Genetic Structure and History of Africans and African Americans
Tishkoff, S. A., Reed, F. A., Friedlaender, F. R., Ehret, C., Ranciaro, A., Froment, A., Hirbo, J. B., Awomoyi, A. A., Bodo, J.-M., Doumbo, O., et al. (2009) · Science · doi:10.1126/science.1172257 · Cited by 1,573 · cited 1×
“Moreover, population admixtures can confound these figures; for instance, 80% of the African American population is from African ancestry and 20% from European ancestry (6).”
BackgroundPrevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196 · cited 1×
“Diabetes complications rates are relatively higher for Latino/Hispanics compared with non-Hispanic whites, including nephropathy, retinopathy, and lower-extremity amputations (186-191).”
BackgroundCarnethon, M. R., Pu, J., Howard, G., Albert, M. A., Anderson, C. A. M., Bertoni, A. G., Mujahid, M. S., Palaniappan, L., Taylor, H. A., Willis, M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000534 · Cited by 1,147
Ethnic disparities in diabetic complications in an insured population
Karter, A. J. (2002) · JAMA · doi:10.1001/jama.287.19.2519 · Cited by 840 · cited 1×
“Diabetes complications rates are relatively higher for Latino/Hispanics compared with non-Hispanic whites, including nephropathy, retinopathy, and lower-extremity amputations (186-191).”
BackgroundViswanathan, M., Golin, C. E., Jones, C. D., Ashok, M., Blalock, S. J., Wines, R. C. M., Coker-Schwimmer, E. J. L., Rosen, D. L., Sista, P., & Lohr, K. N. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00538 · Cited by 754
Li, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E. W., Yang, W., Zhang, B., Shuai, Y., Hong, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70057-9 · Cited by 684 · cited 1×
“Lifestyle interventions in Asians have demonstrated benefits in progression to diabetes from prediabetes, all-cause mortality rates, and cardiovascular mortality (229,239).”
BackgroundNurses as substitutes for doctors in primary care
Laurant, M., van der Biezen, M., Wijers, N., Watananirun, K., Kontopantelis, E., & van Vught, A. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001271.pub3 · Cited by 614 · cited 1×
“Solutions to these issues for Latino/Hispanics may involve greater incorporation of mid-level HCP and community health workers, particularly in large minority urban centers (211,212).”
BackgroundGenome-wide association studies in diverse populations
Rosenberg, N. A., Huang, L., Jewett, E. M., Szpiech, Z. A., Jankovic, I., & Boehnke, M. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2760 · Cited by 566 · cited 1×
“Biological factors can be evaluated using trans-ancestry (or trans-ethnic) genome-wide association studies (GWASs), exome chip association studies, replication studies, and other individual genetic ancestry estimates and informative markers (95-99).”
BackgroundHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Self-citationWheeler, E., Leong, A., Liu, C.-T., Hivert, M.-F., Strawbridge, R. J., Podmore, C., Li, M., Yao, J., Sim, X., Hong, J., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002383 · Cited by 408
Effects of a Traditional Lifestyle on Obesity in Pima Indians
Ravussin, E., Valencia, M. E., Esparza, J., Bennett, P. H., & Schulz, L. O. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.1067 · Cited by 376 · cited 1×
“This is an important factor when comparing Arizona Pima and Mexican Pima peoples, where the former have a much higher diabetes prevalence rate compared with the latter (54% versus 6% for males; 37% versus 11% for females, respectively) (279).”
BackgroundHandelsman, Y., Henry, R. R., Bloomgarden, Z. T., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Ferrannini, E., Fonseca, V. A., Garber, A. J., Grunberger, G., et al. (2016) · Endocrine Practice · doi:10.4158/ep161292.ps · Cited by 358
Self-citationβ Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians
Yabe, D., Seino, Y., Fukushima, M., & Seino, S. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0602-9 · Cited by 328
Mechanick, J. I., Hurley, D. L., & Garvey, W. T. (2017) · Endocrine Practice · doi:10.4158/ep161688.ps · Cited by 320 · cited 5×
“In other words, optimal T2D management requires contextualization but awaits further clinical investigation (Table 4) (109).”
BackgroundMethodResultInfluentialSelf-citationGarber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2019) · Endocrine Practice · doi:10.4158/cs-2018-0535 · Cited by 297
Self-citationGenetic evidence for causal relationships between maternal obesity-related traits and birth weight
Tyrrell, J., Richmond, R. C., Palmer, T. M., Feenstra, B., Rangarajan, J., Metrustry, S., Cavadino, A., Paternoster, L., Armstrong, L. L., De Silva, N. M. G., et al. (2016) · JAMA · doi:10.1001/jama.2016.1975 · Cited by 284
Halder, I., Shriver, M., Thomas, M., Fernandez, J. R., & Frudakis, T. (2008) · Human Mutation · doi:10.1002/humu.20695 · Cited by 274 · cited 1×
“Biological factors can be evaluated using trans-ancestry (or trans-ethnic) genome-wide association studies (GWASs), exome chip association studies, replication studies, and other individual genetic ancestry estimates and informative markers (95-99).”
BackgroundBarriers and facilitators for type-2 diabetes management in South Asians: a systematic review
Sohal, T., Sohal, P., King-Shier, K. M., & Khan, N. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136202 · Cited by 231 · cited 8×
“adherence issues or alternative therapies to their doctors is also a problem (231).”
BackgroundInfluentialCharacterizing the admixed African ancestry of African Americans
Zakharia, F., Basu, A., Absher, D., Assimes, T. L., Go, A. S., Hlatky, M. A., Iribarren, C., Knowles, J. W., Li, J., Narasimhan, B., et al. (2009) · Genome Biology · doi:10.1186/gb-2009-10-12-r141 · Cited by 185
Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function.
Chiu, K. C., Cohan, P., Lee, N. P., & Chuang, L. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1353 · Cited by 154 · cited 1×
“However, the insulin sensitivity index is lowest for Latino/Hispanics, compared with Asian Americans, African Americans, and non-Latino whites (181).”
BackgroundSpencer, M. S., Kieffer, E. C., Sinco, B., Piatt, G., Palmisano, G., Hawkins, J., Lebron, A., Espitia, N., Tang, T., Funnell, M., et al. (2018) · Diabetes Care · doi:10.2337/dc17-0978 · Cited by 153 · cited 1×
“Solutions to these issues for Latino/Hispanics may involve greater incorporation of mid-level HCP and community health workers, particularly in large minority urban centers (211,212).”
BackgroundAssociation of Sickle Cell Trait With Hemoglobin A1c in African Americans
Lacy, M. E., Wellenius, G. A., Sumner, A. E., Correa, A., Carnethon, M. R., Liem, R. I., Wilson, J. G., Sacks, D. B., Jacobs, D. R., Carson, A. P., et al. (2017) · JAMA · doi:10.1001/jama.2016.21035 · Cited by 141 · cited 1×
“where the risk for T2D is underestimated based on fasting and 2-hour postchallenge glucose levels (143).”
BackgroundIdentification and validation of N-acetyltransferase 2 as an insulin sensitivity gene
Knowles, J. W., Xie, W., Zhang, Z., Chennemsetty, I., Assimes, T. L., Paananen, J., Hansson, O., Pankow, J., Goodarzi, M. O., Carcamo-Orive, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74692 · Cited by 141
Ethnic and Racial Differences in Diabetes Care
Bonds, D. E., Zaccaro, D. J., Karter, A. J., Selby, J. V., Saad, M., & Goff, D. C. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1040 · Cited by 122
Barriers to Clinical Research Participation Among African Americans
Luebbert, R., & Perez, A. (2016) · Journal of Transcultural Nursing · doi:10.1177/1043659615575578 · Cited by 113
Mohan, V., Amutha, A., Ranjani, H., Unnikrishnan, R., Datta, M., Anjana, R. M., Staimez, L., Ali, M. K., & Narayan, K. M. V. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0259 · Cited by 82
Cai, X., Gao, X., Yang, W., Chen, Y., Zhang, S., Zhou, L., Han, X., & Ji, L. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12760 · Cited by 64 · cited 1×
“However, in multiple clinical studies, and notwithstanding a theoretical advantage of glucose-lowering in Asians (who may have more of a b-cell impairment), there were similar clinical efficacy and safety data results with sodium-glucose cotransporter-2 inhibitor (SGLT2i) use among Asians, Caucasians, African American…”
ResultKarter, A. J., Lipska, K. J., O’Connor, P. J., Liu, J. Y., Moffet, H. H., Schroeder, E. B., Lawrence, J. M., Nichols, G. A., Newton, K. M., Pathak, R. D., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.02.009 · Cited by 53 · cited 1×
“From a pragmatic standpoint and using the SUPREME-DM network, Karter et al (145) found that African American patients with diabetes had higher rates of hypoglycemia with secretagogue or insulin therapy, compared with Caucasians, Latino/Hispanics, Asians, and the total study population.”
Method
Cited by
Garber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., et al. (2020) · Endocrine Practice · doi:10.4158/cs-2019-0472 · Cited by 598
Self-citationCardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.044 · Cited by 243
Self-citationCardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.046 · Cited by 113
Self-citationFang, L., Sheng, H., Tan, Y., & Zhang, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1088882 · Cited by 52
A Roadmap to an Equitable Digital Diabetes Ecosystem
Kerr, D., Klonoff, D. C., Bergenstal, R. M., Choudhary, P., & Ji, L. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2022.12.016 · Cited by 10
Metadata
- Authors
- Mechanick, J. I., Adams, S., Davidson, J. A., Fergus, I. V., Galindo, R. J., McKinney, K. H., Petak, S. M., Sadhu, A. R., Samson, S. L., Vedanthan, R., & Umpierrez, G. E.
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 25
- Issue
- 7
- Pages
- 729-765
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W2944666043
- Cited by
- 33
- References
- 37
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.